Collaborative Partners
The Sunshine Project consists of a coalition of some of the nation’s
leading pediatric oncologists, pathologists, biologists and medical
information technology specialists.
Co-Lead Principal Investigators
Scott Antonia, MD
Medical Director of Cellular Therapies Core Program Leader, Immunology
H. Lee Moffitt Cancer Center, Tampa
Michael Nieder, MD
Director of Blood and Marrow Transplantation
Pediatric Oncology
All Children’s Hospital, St. Petersburg
Dan Sullivan, MD, PhD
Associate Center Director for Clinical Investigations
Program Leader, Experimental Therapeutics
H. Lee Moffitt Cancer Center, Tampa
Principal Investigator Basic Science
Richard Jove, PhD
Deputy Director, Comprehensive Cancer Center;
Chair and Professor, Division of Molecular Medicine
Co-Director, Experimental Therapeutics Program
City of Hope, Los Angeles
Principal Investigator Translational Research
Dan Sullivan, MD, PhD
Associate Center Director for Clinical Investigations
Program Leader, Experimental Therapeutics
H. Lee Moffitt Cancer Center, Tampa
Co-Principal Investigators Clinical Trials
Dr. Steve Hunger, MD
Chief of Pediatrics Hematology/Oncology
University of Colorado, The Children's Hospital, Denver
Michael Nieder, MD
Director of Blood and Marrow Transplantation
Pediatric Oncology
All Children’s Hospital, St. Petersburg
Principal Investigator Biostatistics
Tanya Trippett, MD
Chair, Pediatric Developmental Therapeutics
Pediatric Hematologist/Oncologist
Memorial Sloan Kettering Cancer Center
Principal Investigator Pathology
Marilyn Bui, MD
Scientific Director, Analytic Microscopy Core Facility
H. Lee Moffitt Cancer Center, Tampa
Participating Institutions
H. Lee Moffitt Cancer Center, Tampa, FL
City of Hope Cancer Center, Los Angeles, CA
All Children’s Hospital, St. Petersburg, FL
Nemours Childrens Clinic, Jacksonville, FL
The Sunshine Project also collaborates with the Pediatric
Oncology Experimental Therapeutics Investigators Consortium (POETIC) on the
clinical trials component of the project. POETIC promotes the early
clinical development of promising therapies for the treatment of
children, adolescents and young adults with cancer, and includes:
Children's Healthcare of Atlanta, Atlanta, GA
MD Anderson Cancer Center, Houston, TX
Memorial Sloan Kettering Cancer Center, New York, NY
Phoenix Children's Hospital, Phoenix, AZ
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
Medical Center, Baltimore, MD
Southern Alberta Children's Cancer Program, Calgary, Alberta Canada
University of Colorado Health Sciences Center/The Children's Hospital,
Denver, CO
University of Florida Shands Cancer Center, Gainesville, FL
Vanderbilt Children's Hospital, Nashville, TN
|